MSKai Spine Imaging Software
AI-powered lumbar spine MRI segmentation and measurement for musculoskeletal diagnostics
Company profile
Company profile
MSKai, LLC has created artificial intelligence-based technology designed to improve spinal patient care and surgical outcomes. The company specializes in utilizing artificial intelligence and machine learning for the analysis of multi-modality musculoskeletal imaging, with a primary focus on spinal conditions. The MSKai System provides automated segmentation and measurement of spinal anatomy and pathologies from MRI and other imaging modalities, delivering both quantitative and qualitative analysis within seconds. The platform features a comprehensive patient library system, AI-generated segmentation overlays, dynamic MRI viewing capabilities, and automated reporting with level-by-level quantitative measurements. Primary applications include supporting pre-surgery authorization processes for patients, assessing the appropriateness of treatment on a post-intervention basis, and facilitating risk assessment of employee-injury potential for employers. The company's mission is to provide accurate, consistent, and unbiased results via transparent musculoskeletal analysis, facilitate timely high-quality care with optimized outcomes for patients, and enable stakeholders' vision for pre-eminent musculoskeletal care. MSKai partners with industry leaders to introduce and commercialize their innovation to efficiently optimize the use of medical imaging. The company has received FDA 510(k) clearance for clinical use and has been recognized with the Best Technology in Spine Award.
Company description MSKai official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas deployment with recorded integration context.
Company milestones
FDA 510(k) clearance received for spine imaging software; Won Best Technology in Spine Award; Released lumbar spine MRI segmentation and measurement AI technology
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI-powered lumbar spine MRI segmentation and measurement for musculoskeletal diagnostics
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Molecules (Basel, Switzerland) · Nov 25, 2015
Chemiluminescence-imaging detection of DNA on a solid-phase membrane by using a peroxidase-labeled macromolecular probe.Talanta · Jul 1, 2015
Selective, sensitive and fluorometric determination of urinary cytosine with 4-trifluoromethylbenzamidoxime and N,N-dimethylformamide.Clinica chimica acta; international journal of clinical chemistry · Feb 15, 2014
Dendrimer-like polymeric DNAs as chemiluminescence probes for amplified detection of telomere DNA on a solid-phase membrane.Chemical communications (Cambridge, England) · Jan 25, 2014
Sensitive determination of a beta-lactam antibiotic, cefaclor by liquid chromatography with chemiluminescence detection.Journal of pharmaceutical and biomedical analysis · Jan 15, 2003
Clinical validation
No linked records are currently available.
Regulatory
K240793 · 510k · Dec 16, 2024
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Identifies, measures, and classifies spinal anatomy and pathologies within seconds
Provides accurate, consistent, and unbiased results via transparent musculoskeletal analysis
05 · Leadership
Leadership profiles and professional links from the current Company record.
Jeff Engelberg
Chief Executive Officer, Founder
Chip Wade
Chief Operating Officer, Founder
John Burrow
Chief Development Officer, Founder
Adam Bruggeman
Chief Medical Officer, Founder
Sreenivas Rangan Sukumar
Chief Technology Officer, Founder
Chris Lyons
Chief Commercialization Officer
Julie Wells
General Counsel
Janelle Burns
Chief Privacy Officer
06 · Company updates
Recent articles published on MSKai's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies developing surgical technologies enhanced by AI, including robotic surgical systems, AI-powered surgical assistance and navigation tools, autonomous surgical robotics, and surgical data and analytics platforms. Covers both the performance of surgery and the analysis of surgical outcomes and OR efficiency.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.